Login

Ben McMillan, founder and CIO of IDX Digital Assets, discusses the key factors driving the crypto market in an interview with CNBC Crypto World. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Focused on becoming a platform of life services for older adults - Katie Potter, president and chief executive officer, Five Star Senior Living Inc.
00:10:00
Brinks CEO Asserts Cash Use is on the Rise, Defying Pandemic's Economic Impact | Douglas A Pertz - CEO of Brink's
00:10:00
Streamlining Tax Filing with Mercadian's TaxCaddy Integration
00:10:00
Cardio Therapeutics aims to revolutionize cardiovascular medicine through groundbreaking research and pivotal clinical trials | David Elsley, CEO, Cardiol Therapeutics Inc.
00:10:00
Hyosung's Expansion in India: A Promising Partnership for Growth | Hyun-Joon Cho, Chairman of Hyosung Corp
00:00:00
Medicure Inc (MPH-TSX.V) Interview with CEO Dr. Albert Friesen - Albert D. Friesen, PhD. Chief Executive Officer and Chairman of the Board, Medicure Inc
00:00:00
Executive interview – Dr Heikki Lanckriet, CEO, Expedeon
00:10:00
Christophe Bavière on FinTech, Brexit, and the Future of Innovation | Christophe Bavière, CEO, Idinvest Partners.
00:10:00
Ratos Q2 2022 Earnings: CEO Jonas Wiström's Highlights and Insights | Jonas Wiström, CEO, Ratos.
00:10:00
Unpacking the Impact of ESG on Modern Investment Strategies | Jennifer Luzzatto, President, Summit Financial Partners, Inc.
00:00:00
James Czirr, Executive Chairman of Galectin Therapeutics, Inc.
00:10:00
supporting early stage companies through angel investing|Charley Ma, GM, Fintech at Alloy

© 2017 - Neuhu+